VF
BIS icon

Virtu Financial’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Virtu Financial’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,384
Closed -$319K – 1468
2019
Q1 		$319K Buy
+2,384
New +$337K 0.02% 756
2018
Q4 		– Sell
-4,362
Closed -$545K – 1559
2018
Q3 		$545K Buy
4,362
+2,485
+132% +$335K 0.03% 557
2018
Q2 		$292K Sell
1,877
-1,622
-46% -$270K 0.02% 1174
2018
Q1 		$592K Sell
3,499
-5,801
-62% -$931K 0.03% 614
2017
Q4 		$1.64M Buy
9,300
+5,392
+138% +$957K 0.09% 254
2017
Q3 		$643K Buy
3,908
+1,437
+58% +$259K 0.03% 721
2017
Q2 		$479K Sell
2,471
-755
-23% -$165K 0.07% 216
2017
Q1 		$719K Buy
3,226
+425
+15% +$100K 0.07% 179
2016
Q4 		$784K Buy
+2,801
New +$766K 0.08% 185
2016
Q3 		– Sell
-8,183
Closed -$2.72M – 369
2016
Q2 		$2.72M Sell
8,183
-4,687
-36% -$1.48M 0.36% 52
2016
Q1 		$4.49M Buy
+12,870
New +$4.48M 0.62% 32
2015
Q4 		– Sell
-18,194
Closed -$5.61M – 370
2015
Q3 		$5.61M Buy
18,194
+15,664
+619% +$3.7M 0.73% 29
2015
Q2 		$581K Buy
+2,530
New +$628K 0.05% 188
2014
Q4 		– Sell
-464
Closed -$224K – 307
2014
Q3 		$224K Buy
+464
New +$247K 0.02% 263

Other funds holding BIS

WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Virtu Financial's BIS Position: Q2 2019 in Review

Virtu Financial sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q2 2019, closing a stake of 2,384 shares — an estimated $319K sold.

Virtu Financial first reported a position in BIS in Q3 2014 and held it in 14 quarters. The position peaked at $5.61M in Q3 2015. 10 funds tracked by Wall St. Rank hold BIS as of Q2 2019.

  • Virtu Financial reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q2 2019 after selling out during the quarter.
  • Virtu Financial sold 2,384 ProShares UltraShort NASDAQ Biotechnology shares in Q2 2019, an estimated $319K.
  • Virtu Financial first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q3 2014 and held it in 14 quarters.
  • Virtu Financial's ProShares UltraShort NASDAQ Biotechnology position peaked at $5.61M in Q3 2015.
  • 10 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q2 2019.

Based on Virtu Financial's 13F filing for Q2 2019, filed 13 Aug 2019.